FDA
approval
· 2018-08-22
FDA Approved: INVELTYS — Original Application (ALCON LABORATORIES, INC.)
Summary
FDA approved INVELTYS (loteprednol etabonate) ophthalmic suspension 1% from Alcon Laboratories as an original application for the treatment of postoperative ocu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for INVELTYS (LOTEPREDNOL ETABONATE)